DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.
One wealth manager who pays more than $20,000 a year for membership to a longevity clinic in London was told he had some calcification in the arteries in his neck, as well as an elevated genetic risk ...
A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural alterations in the brains of people with bipolar disorder (BD), a chronic ...